Biomarkers to Measure Treatment Response for Alcohol Dependence
NCT ID: NCT02315885
Last Updated: 2022-09-01
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
29 participants
INTERVENTIONAL
2015-07-31
2019-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Motivational and Cognitive Intervention for College Drinkers
NCT01204229
Adapting a Secondary Prevention Program for Nonstudent Emerging Adult Drinkers
NCT03381391
Impact of a Brief Motivational Interview on Drinking Behaviors of At Risk Drinkers Screened in the Emergency Room
NCT00183183
Differences in Cannabis Impairment and Its Measurement Due to Route of Administration
NCT03122691
Preliminary Effectiveness of Remotely Monitored Blood Alcohol Concentration Device as Treatment Modality
NCT04380116
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
OTHER
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
placebo alcohol
\<0.05% alcohol
Alcohol administration; Placebo administration
consumption of 3 alcohol doses (2 regular and one placebo) each within 2h on separate days
alcohol middle dose
alcohol dose=0.45g/kg for women and 0.5g/kg for men
Alcohol administration; Placebo administration
consumption of 3 alcohol doses (2 regular and one placebo) each within 2h on separate days
alcohol high dose
alcohol dose=0.90g/kg for women and 1.0g/kg for men
Alcohol administration; Placebo administration
consumption of 3 alcohol doses (2 regular and one placebo) each within 2h on separate days
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Alcohol administration; Placebo administration
consumption of 3 alcohol doses (2 regular and one placebo) each within 2h on separate days
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
21 Years
65 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Maryland, Baltimore
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Chamindi Seneviratne, MD
Assistant Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Clinical Neurobehavioral Center
Columbia, Maryland, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
HP-00060091
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.